Dravet综合征患者癫痫手术控制癫痫发作:这是一种安全实用的选择吗?

IF 3.4 2区 医学 Q2 CLINICAL NEUROLOGY
Keith Starnes, Elaine Wirrell, M Scott Perry
{"title":"Dravet综合征患者癫痫手术控制癫痫发作:这是一种安全实用的选择吗?","authors":"Keith Starnes, Elaine Wirrell, M Scott Perry","doi":"10.1080/14737175.2025.2562118","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Dravet syndrome is a severe developmental and epileptic encephalopathy presenting in childhood with drug resistant seizures and multiple comorbidities including developmental and cognitive delays. While medical therapy has continued to advance, leading to improved seizure control, outcomes such as seizure freedom remain elusive. As the underlying cause of Dravet syndrome is a genetic channelopathy, epilepsy surgery is rarely considered.</p><p><strong>Areas covered: </strong>The authors weigh up the potential benefits of surgical therapy when seizure reduction, but not seizure freedom, is expected, discussing the literature related to surgical therapy in patients with Dravet syndrome and other similar genetic conditions.</p><p><strong>Expert opinion: </strong>In general, people with Dravet syndrome are rarely favorable candidates for epilepsy surgery, yet surgery is not necessarily contraindicated. Meaningful seizure reduction can be achieved in highly selected cases with perhaps the most benefit arising from neuromodulation procedures such as vagus nerve stimulation. It remains uncertain whether seizure reduction following surgery contributes to any non-seizure benefits.</p>","PeriodicalId":12190,"journal":{"name":"Expert Review of Neurotherapeutics","volume":" ","pages":"1-6"},"PeriodicalIF":3.4000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?\",\"authors\":\"Keith Starnes, Elaine Wirrell, M Scott Perry\",\"doi\":\"10.1080/14737175.2025.2562118\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Dravet syndrome is a severe developmental and epileptic encephalopathy presenting in childhood with drug resistant seizures and multiple comorbidities including developmental and cognitive delays. While medical therapy has continued to advance, leading to improved seizure control, outcomes such as seizure freedom remain elusive. As the underlying cause of Dravet syndrome is a genetic channelopathy, epilepsy surgery is rarely considered.</p><p><strong>Areas covered: </strong>The authors weigh up the potential benefits of surgical therapy when seizure reduction, but not seizure freedom, is expected, discussing the literature related to surgical therapy in patients with Dravet syndrome and other similar genetic conditions.</p><p><strong>Expert opinion: </strong>In general, people with Dravet syndrome are rarely favorable candidates for epilepsy surgery, yet surgery is not necessarily contraindicated. Meaningful seizure reduction can be achieved in highly selected cases with perhaps the most benefit arising from neuromodulation procedures such as vagus nerve stimulation. It remains uncertain whether seizure reduction following surgery contributes to any non-seizure benefits.</p>\",\"PeriodicalId\":12190,\"journal\":{\"name\":\"Expert Review of Neurotherapeutics\",\"volume\":\" \",\"pages\":\"1-6\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-09-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Neurotherapeutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/14737175.2025.2562118\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Neurotherapeutics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737175.2025.2562118","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

Dravet综合征是一种严重的发育性和癫痫性脑病,儿童期表现为耐药癫痫发作和多种合并症,包括发育和认知迟缓。虽然医学治疗不断进步,导致癫痫控制得到改善,但癫痫发作自由等结果仍然难以捉摸。由于Dravet综合征的根本原因是遗传通道病变,癫痫手术很少被考虑。涵盖的领域:作者权衡了手术治疗的潜在益处,当癫痫发作减少,而不是癫痫发作自由,是预期的,讨论了与Dravet综合征和其他类似遗传疾病患者的手术治疗相关的文献。专家意见:一般来说,患有Dravet综合征的人很少是癫痫手术的有利候选人,但手术不一定是禁忌。有意义的癫痫发作减少可以在高度选定的病例中实现,可能最大的益处来自神经调节程序,如迷走神经刺激。手术后癫痫发作的减少是否会带来非癫痫发作的益处仍不确定。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Epilepsy surgery for seizure control in individuals with Dravet syndrome: is it a safe and practical option?

Introduction: Dravet syndrome is a severe developmental and epileptic encephalopathy presenting in childhood with drug resistant seizures and multiple comorbidities including developmental and cognitive delays. While medical therapy has continued to advance, leading to improved seizure control, outcomes such as seizure freedom remain elusive. As the underlying cause of Dravet syndrome is a genetic channelopathy, epilepsy surgery is rarely considered.

Areas covered: The authors weigh up the potential benefits of surgical therapy when seizure reduction, but not seizure freedom, is expected, discussing the literature related to surgical therapy in patients with Dravet syndrome and other similar genetic conditions.

Expert opinion: In general, people with Dravet syndrome are rarely favorable candidates for epilepsy surgery, yet surgery is not necessarily contraindicated. Meaningful seizure reduction can be achieved in highly selected cases with perhaps the most benefit arising from neuromodulation procedures such as vagus nerve stimulation. It remains uncertain whether seizure reduction following surgery contributes to any non-seizure benefits.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Expert Review of Neurotherapeutics
Expert Review of Neurotherapeutics Medicine-Neurology (clinical)
CiteScore
7.00
自引率
2.30%
发文量
61
审稿时长
4-8 weeks
期刊介绍: Expert Review of Neurotherapeutics (ISSN 1473-7175) provides expert reviews on the use of drugs and medicines in clinical neurology and neuropsychiatry. Coverage includes disease management, new medicines and drugs in neurology, therapeutic indications, diagnostics, medical treatment guidelines and neurological diseases such as stroke, epilepsy, Alzheimer''s and Parkinson''s. Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信